Evidence map›Paper›PMID 41299692›Full record

ArticleBiomedical engineering online2025

Inhibition of Na

Ameneh Ahrari, Saber Khodabandeh, Haleh Akhavan Niaki, Hadi Zare-Zardini

Abstract read
In one paragraph

Article in Biomedical engineering online, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ameneh AhrariDepartment of Marine Biology, Tarbiat Modares University, Tehran, Iran.
Saber KhodabandehDepartment of Marine Biology, Tarbiat Modares University, Tehran, Iran. Surp78@gmail.com.
Haleh Akhavan NiakiDepartment of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Hadi Zare-ZardiniDepartment of Biomedical Engineering, Meybod University, Meybod, Iran. hzare@meybod.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe Na

methodsTTX was extracted using 2% acetic acid-methanol (v/v). To determine the lethal concentration of TTX, three concentrations of the TTX extract (1.5, 2.0, and 3.0 mg/kg) were injected into transgenic mice that had already been induced by the 4T1 cell line and bearing tumors. After 7-8 weeks of monitoring tumor volume, the mice were killed, and a portion of the tumors was fixed in Bouin's fixative for immunohistological analysis, while the rest was frozen for biochemical analysis.

resultsBiometric analysis of Balb/c nu mice indicated a notable reduction in tumor volume progression in the group subjected to TTX extract compared to the control group. Furthermore, immunohistochemical and biochemical analysis demonstrated a decrease in the intensity and activity of NKA in the TTX extract group compared to the control group.

conclusionOur results indicate that TTX extract may have anti-tumor effects by inhibiting NKA activity. Therefore, considering the presence of TTX in the pufferfish extract, TTX could be a promising therapeutic candidate for controlling metastatic breast tumor growth and metastasis through NKA inhibition.

Indexed as

Breast NeoplasmsEnzyme InhibitorsSodium-Potassium-Exchanging ATPaseTetrodotoxinXenograft Model Antitumor AssaysAnimalsCell Line, TumorFemaleMiceMice, Inbred BALB CEnzyme InhibitorsSodium-Potassium-Exchanging ATPaseTetrodotoxin4T1 cell lineBreast tumorNa+K+-ATPase (NKA)Persian GulfPufferfishTetrodotoxin (TTX) extract

Identifiers

PMID41299692
PMCPMC12659036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.